Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Fraunhofer IZI Granted Manufacturing Authorization for Second GMP Facility

Published: Thursday, January 23, 2014
Last Updated: Wednesday, January 22, 2014
Bookmark and Share
Company’s cleanroom capacities shall again be expanded by mid-2015.

On 10 January 2014, the existing manufacturing authorization according to Art. 13 of the German Drug Act (AMG) of the Fraunhofer Institute for Cell Therapy and Immunology IZI was expanded to cover the first extension of the existing cleanroom facility.

After extensive qualification and inspection by the Regional Council of Saxony, the »Certificate of GMP-Compliance of a Manufacturer« was also updated. This seal of approval doubles the institute's capacities to manufacture cell-based medicinal products, or so-called »Advanced Therapy Medicinal Products« (ATMP).

Cell therapy products for clinical studies can now be produced on a total cleanroom area of over 750 m² in sixteen cleanroom class B manufacturing rooms to be operated independently.

The specific facility design allows for the parallel manufacture of several cell therapy products without the risk of mutual cross-contamination.

A separate part of the facility is furthermore specifically designed for the manufacture of products that must meet special safety requirements with respect to genetic engineering or protection against infection.

The operation of two separate and independent facilities provides maximum flexibility and continuity in the manufacturing processes, especially for bridging regularly scheduled maintenance periods.

A major part of the new facility is already booked out with manufacturing projects for various different clinical studies up to Phase III.

The staff consisting of 61 qualified employees currently handles both GMP facilities, the associated projects and the comprehensive quality assurance system. These professionals have profound expertise in the production and quality control of autologous and allogeneic cell therapy products, process development, and the validation of production processes as well as quality controls.

The cleanroom capacities of the Fraunhofer IZI shall again be expanded with a third construction section by mid-2015 to meet the continuously growing demand in this business sector.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Faecal Bacteria Linked to Body Fat
Researchers at King’s College London have found a new link between the diversity of bacteria in human poo – known as the human faecal microbiome - and levels of abdominal body fat.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Anti-Inflammatory Drugs Could Strengthen Airway Immunity
Mold toxins can weaken the airways' clearing mechanisms and immunity, but PKC inhibitors showed promise as a treatment.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Vaccine Against Common Cold Achievable
Researchers suggest that a vaccine against rhinoviruses is possible using variant virus vaccines.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Uncovering Cancer’s ‘Invisibility Cloak’
Researchers discover cancer cell mechanism to become invisible to the body's immune system.
Culex Mosquitoes Do Not Transmit Zika
A study of the Culex species mosquito appears to show that the species does not transmit Zika virus.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!